Combination of Whole-Body Baseline CT Radiomics and Clinical Parameters to 
Predict Response and Survival in a Stage-IV Melanoma Cohort Undergoing 
Immunotherapy

Peisen, Felix; Hänsch, Annika; Hering, Alessa; Brendlin, Andreas S.; Afat, Saif; Nikolaou, Konstantin; Gatidis, Sergios; Eigentler, Thomas; Amaral, Teresa; Moltz,  Jan H.; Othman, Ahmed E.

doi:10.3390/cancers14122992

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Combination of Whole-Body Baseline CT Radiomics and Clinical Parameters to Predict Response and Survival in a Stage-IV Melanoma Cohort Undergoing Immunotherapy

MPS-Authors

/persons/resource/persons289328

Gatidis, Sergios
Dept. Empirical Inference, Max Planck Institute for Intelligent Systems, Max Planck Society;
External Organizations;

External Resource

https://doi.org/10.3390/cancers14122992
(Publisher version)

https://europepmc.org/article/MED/35740659
(Publisher version)

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Peisen, F., Hänsch, A., Hering, A., Brendlin, A. S., Afat, S., Nikolaou, K., et al. (2022). Combination of Whole-Body Baseline CT Radiomics and Clinical Parameters to Predict Response and Survival in a Stage-IV Melanoma Cohort Undergoing Immunotherapy. Cancers / Molecular Diversity Preservation International (MDPI), 14(12): 2992. doi:10.3390/cancers14122992.

Cite as: https://hdl.handle.net/21.11116/0000-000D-D09B-9

Abstract

There is no abstract available